Pros, cons, and costs of INFUSE in spinal surgery

Surgical Neurology International

Volumn 2, Issue 1, 2011, Pages

  Epstein, Nancy ^a,b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

bone morphogenetic protein; INFUSE (rhBMP 2); off label use; spinal surgery

Indexed keywords

COLLAGEN TYPE 1; INFUSE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ALLERGY; ANTERIOR SPINE FUSION; DRUG COST; DURA MATER; HEALTH INSURANCE; HUMAN; LUMBAR SPINE; MEDICARE; NERVE INJURY; POSTOPERATIVE COMPLICATION; PREGNANCY; PRIORITY JOURNAL; REIMBURSEMENT; RESPIRATORY FAILURE; REVIEW; SEXUAL DYSFUNCTION; SPINAL PARALYSIS; SPINE FUSION; SPINE SURGERY; THORAX SURGERY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 79952998211     PISSN: None     EISSN: 21527806     Source Type: Journal    
DOI: 10.4103/2152-7806.76147     Document Type: Review

References (15)

1. Balseiro S, Nottmeier EW. Literature review for infuse: Vertebral osteolysis originating from subchondral cyst end plate defects in transforaminal lumbar interbody fusion using rhBMP-2. Report of two cases. Spine J 2010;10:e6-10.
2. Burkus JK, Transfeldt EE, Kitchel SH, Watkins RG, Balderston RA. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine 2002;27:2396-408. (Pubitemid 35266228)
3. Carreon LY, Glassman SD, Brock DC, Dimar JR, Puno RM, Campbell MJ. Adverse events in patients re-exposed to bone morphogenetic protein for spine surgery. Spine 2008;33:391-3. (Pubitemid 351286532)
4. Deutsch H. High-dose bone morphogenetic protein-induced ectopic abdomen bone growth. Spine J 2010;10:e1-4.
5. Glassman SD, Carreon LY, Campbell MJ, Johnson JR, Puno RM, Djurasovic M, et al. The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion. Spine J 2008;8:443-8. (Pubitemid 351608965)
6. Glassman SD, Carreon LY, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, et al. RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: A randomized, controlled trial in patients over sixty years of age. Spine 2008;33:2843-9.
7. Glassman SD, Howard J, Dimar J 2 nd, Sweet A, Wilson G, Carreon L. Complications with rhBMP-2 in posterolateral spine fusion: A consecutive series of one thousand thirty-seven cases. Spine 2010 in press.
8. Mannion RJ, Nowitzke AM, Wood MJ. Promoting Fusion in Minimally Invasive Lumbar Interbody Stabilization with Low-dose Bone Morphogenic protein-2-but What Is the Cost?, Spine J 2010 in Press.
9. Mroz TE, Wang JC, Hashimoto R, Norvell DC. Complications related to osteobiologics use in spine surgery: A systematic review. Spine 2010;35:S86-104.
10. Owens K, Glassman SD, Howard JM, Djurasovic M, Witten JL, Carreon LY. Perioperative complications with rhBMP-2 in transforaminal lumbar interbody fusion. Eur Spine J 2010 in press.
11. Shahlaie K, Kim KD. Occipitocervical fusion using recombinant human bone morphogenetic protein-2: Adverse effects due to tissue swelling and seroma. Spine 2008;33:2361-6.
12. Shields LB, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine (Phila Pa 1976) 2006;31:542-7.
13. Stambough JL, Clouse EK, Stambough JB. Instrumented one and two level posterolateral fusions with recombinant human bone morphogenetic protein-2 and allograft: A computed tomography study. Spine 2010;35:124-9.
14. Wong DA, Kumar A, Jatana S, Ghiselli G, Wong K. Neurologic impairment from ectopic bone in the lumbar canal: A potential complication of off-label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 2008;8:1011-8.
15. Yaremchuk KL, Toma MS, Somers ML, Peterson E. Acute airway obstruction in cervical spinal procedures with bone morphogenetic proteins, Laryngoscope 2010;120:1954-7.